These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16340533)

  • 1. Effective transscleral delivery of two retinal anti-angiogenic molecules: carboxyamido-triazole (CAI) and 2-methoxyestradiol (2ME2).
    Cruysberg LP; Franklin AJ; Sanders J; Self C; Yuan P; Csaky KG; Robinson MR; Kohn EC; Edelhauser HF
    Retina; 2005 Dec; 25(8):1022-31. PubMed ID: 16340533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleral permeability of a small, single-stranded oligonucleotide.
    Shuler RK; Dioguardi PK; Henjy C; Nickerson JM; Cruysberg LP; Edelhauser HF
    J Ocul Pharmacol Ther; 2004 Apr; 20(2):159-68. PubMed ID: 15117572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transscleral permeability of fluorescent-labeled antibiotics.
    Kao JC; Geroski DH; Edelhauser HF
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):1-10. PubMed ID: 15718823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant.
    Cruysberg LP; Nuijts RM; Gilbert JA; Geroski DH; Hendrikse F; Edelhauser HF
    Curr Eye Res; 2005 Aug; 30(8):653-60. PubMed ID: 16109645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system.
    Cruysberg LP; Nuijts RM; Geroski DH; Koole LH; Hendrikse F; Edelhauser HF
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):559-69. PubMed ID: 12537682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of high molecular weight compounds through sclera.
    Ambati J; Canakis CS; Miller JW; Gragoudas ES; Edwards A; Weissgold DJ; Kim I; Delori FC; Adamis AP
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1181-5. PubMed ID: 10752958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery.
    Amaral J; Fariss RN; Campos MM; Robison WG; Kim H; Lutz R; Becerra SP
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4383-92. PubMed ID: 16303924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.
    Cruysberg LP; Nuijts RM; Geroski DH; Gilbert JA; Hendrikse F; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3790-4. PubMed ID: 16186364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.
    Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4513-22. PubMed ID: 17003447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human sclera barrier properties for transscleral delivery of bevacizumab and ranibizumab.
    Wen H; Hao J; Li SK
    J Pharm Sci; 2013 Mar; 102(3):892-903. PubMed ID: 23212655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigation on intestinal absorption of a new anticancer drug, 2-methoxyestradiol.
    Guo XH; Zhang N; Cui FD; Du B; Zhang ZZ
    Pharmazie; 2009 Nov; 64(11):748-51. PubMed ID: 20099520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human scleral hydraulic conductivity: age-related changes, topographical variation, and potential scleral outflow facility.
    Jackson TL; Hussain A; Hodgetts A; Morley AM; Hillenkamp J; Sullivan PM; Marshall J
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4942-6. PubMed ID: 17065511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors.
    Dahut WL; Lakhani NJ; Gulley JL; Arlen PM; Kohn EC; Kotz H; McNally D; Parr A; Nguyen D; Yang SX; Steinberg SM; Venitz J; Sparreboom A; Figg WD
    Cancer Biol Ther; 2006 Jan; 5(1):22-7. PubMed ID: 16357512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
    Olsen TW; Edelhauser HF; Lim JI; Geroski DH
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1893-903. PubMed ID: 7543465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of benzalkonium chloride on transscleral drug delivery.
    Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
    Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of molecular shape, conformability, net surface charge, and tissue interaction on transscleral macromolecular diffusion.
    Srikantha N; Mourad F; Suhling K; Elsaid N; Levitt J; Chung PH; Somavarapu S; Jackson TL
    Exp Eye Res; 2012 Sep; 102():85-92. PubMed ID: 22846670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an ex vivo model implication for carrier-mediated retinal drug delivery.
    Kansara V; Mitra AK
    Curr Eye Res; 2006 May; 31(5):415-26. PubMed ID: 16714233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.
    Mooberry SL
    Curr Opin Oncol; 2003 Nov; 15(6):425-30. PubMed ID: 14624224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.